Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14030823 | 0.81 | MIF (0.32) | — | |
| SCHEMBL4563833 | 0.74 | — | — | |
| SCHEMBL1157926 | 0.61 | — | — | |
| SCHEMBL8849001 | 0.56 | — | — | |
| SCHEMBL19436418 | 0.54 | — | — | |
| SCHEMBL17104914 | 0.54 | — | — | |
| SCHEMBL20042488 | 0.54 | DAO (0.36) | — | |
| SCHEMBL8358879 | 0.54 | — | — | |
| SCHEMBL10758404 | 0.52 | — | — | |
| SCHEMBL10982343 | 0.50 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2872520-B1 | TRIARYLMETHYL RADICALS | BRACCO IMAGING SPA (IT) | 2016-09-14 | — | — | EP | disclosed |
| US-9381257-B2 | Triarylmethyl radicals | BRACCO IMAGING S.P.A. (IT) | 2016-07-05 | — | — | US | disclosed |
| US-9381257-B2 | Triarylmethyl radicals | BRACCO IMAGING S.P.A. (IT) | 2016-07-05 | — | — | US | disclosed |
| US-20150151009-A1 | TRIARYLMETHYL RADICALS | BRACCO IMAGING S.P.A. (IT) | 2015-06-04 | — | — | US | disclosed |
| US-20150151009-A1 | TRIARYLMETHYL RADICALS | BRACCO IMAGING S.P.A. (IT) | 2015-06-04 | — | — | US | disclosed |
| WO-2014009240-A1 | TRIARYLMETHYL RADICALS | BRACCO IMAGING SPA (IT) | 2014-01-16 | — | — | WO | disclosed |
| US-5827501-A | INERT TRIARYLMETHYL FREE RADICAL CONTRAST AGENTS FOR ELECTRON SPIN RESONANCE (ESR) ENHANCED MAGNETIC RESONANCE (EMR) IMAGING | NYCOMED IMAGING AS (NO) | 1998-10-27 | — | — | US | disclosed |
| US-5599522-A | CONTRAST ENHANCING AGENTS | NYCOMED IMAGING AS (NO) | 1997-02-04 | — | — | US | disclosed |
| EP-0515458-B1 | TRIARYLMETHYL RADICALS AND THE USE OF INERT CARBON FREE RADICALS IN MRI | NYCOMED INNOVATION AB (SE) | 1995-08-23 | — | — | EP | disclosed |
| EP-0515458-A1 | TRIARYLMETHYL RADICALS AND THE USE OF INERT CARBON FREE RADICALS IN MRI. | HAFSLUND NYCOMED INNOVATION (SE) | 1992-12-02 | — | — | EP | disclosed |
| WO-1991012024-A1 | TRIARYLMETHYL RADICALS AND THE USE OF INERT CARBON FREE RADICALS IN MRI | HAFSLUND NYCOMED INNOVATION AB (SE) | 1991-08-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150151009-A1 | TRIARYLMETHYL RADICALS | MT-ND4L, TXN2, TXNRD2 | TDP1 1209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.